speb/financial-data huggingface dataset:
THYROCARE.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 0.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 316400000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 161200000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 0.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 161200000.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 0.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: 0.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 221000000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 33000000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 2627200000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 9200000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Minority Interests: 1300000.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 300000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Net Income: 644900000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 644900000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 643600000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 644900000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 644900000.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 874100000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 643600000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Net Interest Income: -34500000.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 12600000.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 0.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 0.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -34500000.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 9200000.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 1300000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Net PPE: 1944300000.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -415500000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 4332300000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 122700000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 9800000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 33000000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 297000000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 1238500000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Normalized Income: 602763415.74
THYROCARE.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 1293100000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Operating Income: 846200000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Operating Revenue: 5172000000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 158789037.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 53200000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 79100000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 234500000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 7900000.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 9700000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 50700000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 4400000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 848200000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Other Payable: 100200000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Other Properties: 1928200000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 5500000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 1330000000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Other Special Charges: -4300000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Payables: 341700000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 88300000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Pretax Income: 885900000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 95200000.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: 0.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -1919900000.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -436500000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 260300000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 1632300000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 387100000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 56100000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 56100000.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: 0.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: -55300000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 0.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 3434200000.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Sale Of Business: 0.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 1932500000.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 21000000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 201800000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 435300000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Share Issued: 158790129.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Special Income Charges: 4300000.00
THYROCARE.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 211700000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 5343000000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 4332300000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 15863415.74
THYROCARE.NS income_statement (annual, 2023-03-31) — Tax Provision: 242300000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.27
THYROCARE.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -284600000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Total Assets: 6327200000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 5343000000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Total Debt: 233100000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 5352200000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Total Expenses: 4325800000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 975000000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 3597800000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 204000000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 24800000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 18300000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 58000000.00
THYROCARE.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 58000000.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Treasury Shares Number: 1092.00
THYROCARE.NS balance_sheet (annual, 2023-03-31) — Working Capital: 1958400000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — +Operating Expense: 3084700000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — +Total Revenue: 5678800000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 401100000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 434700000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -1924500000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 752200000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -228000000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 52200000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 158812761.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Basic EPS: 4.46
THYROCARE.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 177700000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 643300000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -615800000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 207400000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 529500000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 93000000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 1766300000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -952700000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 93000000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -198500000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 21600000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 3800000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Change In Payable: 161200000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 328200000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 301600000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -84700000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Common Stock: 529500000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -952700000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 5267700000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 200000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 25500000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 1667000000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Current Assets: 2785100000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 89400000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Current Debt: 106900000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 196300000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 12900000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 904800000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 28100000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Depreciation: 470100000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 470100000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 470100000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 470100000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 159123855.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Diluted EPS: 4.45
THYROCARE.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 707600000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 100000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — EBIT: 1001800000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — EBITDA: 1471900000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — End Cash Position: 93000000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -848100000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 31300000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 1060500000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -57900000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 9300000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 330100000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Goodwill: 1040300000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 1047200000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 662700000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 3961500000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Gross Profit: 4011800000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Interest Expense: 42000000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 42000000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Interest Income: 27100000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 27100000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -66400000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 9800000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Inventory: 475200000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 5483700000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -912900000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 0.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Investmentsin Associatesat Cost: 256200000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 200000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 286200000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 317200000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 118000000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 109100000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 227100000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 286200000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -70300000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 256200000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 30600000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 2975500000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 8600000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Minority Interests: 12700000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: -35200000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 200000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Net Debt: 123000000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Net Income: 707600000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 707600000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 694900000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 707600000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 707600000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 955900000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 694900000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Net Interest Income: -28200000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -278800000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 215900000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 215900000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -28200000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 12100000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -100000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Net PPE: 2037000000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -608600000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 4220500000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 148200000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 0.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 30600000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 162900000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 1423400000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Normalized Income: 672485757.45
THYROCARE.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 1676300000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Operating Income: 927100000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Operating Revenue: 5678800000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 158856936.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: -100000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 75600000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 4300000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 385300000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 6900000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 32200000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 100000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: -4300000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 8300000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 877800000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Other Payable: 45400000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Other Properties: 2011600000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 6900000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 1673300000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Other Special Charges: 9300000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Payables: 446600000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 101900000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Pretax Income: 959800000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 88300000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: -35200000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -278800000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -615800000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 443900000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 1667000000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 470100000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 41500000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 41500000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -70300000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 100000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 3191900000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 7200000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 326600000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 656700000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Share Issued: 158858028.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Special Income Charges: -9300000.00
THYROCARE.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 166700000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 5267700000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 4220500000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 13385757.45
THYROCARE.NS income_statement (annual, 2024-03-31) — Tax Provision: 264900000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.28
THYROCARE.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -289900000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Total Assets: 6438800000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 5376800000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Total Debt: 423400000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 5276300000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Total Expenses: 4751700000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 1162500000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 3653700000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 257700000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 13300000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 12900000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 48500000.00
THYROCARE.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 48500000.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 1092.00
THYROCARE.NS balance_sheet (annual, 2024-03-31) — Working Capital: 1880300000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 457200000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 479300000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 63700000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 184300000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 529500000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 457300000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 1400600000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 529500000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 4881600000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 6000000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 2448400000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 84700000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 1200000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 85900000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 948400000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 40000000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 1052500000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 1080200000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 1872600000.00
THYROCARE.NS income_statement (quarterly, 2024-09-30) — Interest Expense: 7600000.00
THYROCARE.NS income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 7600000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 440700000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 4882800000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 63700000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 99600000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 0.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 99600000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 249700000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 36200000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 5100000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 1872600000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 3801400000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 173400000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 158856936.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 127800000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 29900000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 4352100000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 27700000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 15400000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: -100000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 1866600000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 943300000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Payables: 509600000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 158858028.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 4881600000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 3801400000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 5970800000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 4881600000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 185500000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 4886700000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 1084100000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 3522500000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 135700000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 52400000.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Treasury Shares Number: 1092.00
THYROCARE.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 1500000000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 960900000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 1659200000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 451600000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 170600000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 170600000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 191100000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — EBIT: 285200000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — EBITDA: 455800000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 1207600000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 6000000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 6000000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Minority Interests: 1600000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Net Income: 191100000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 191100000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 189500000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 191100000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 191100000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 189500000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -6000000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -6000000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 455800000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 191100000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Operating Income: 246700000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 1659200000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 40100000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 439400000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 279200000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 451600000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 170600000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 89700000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.32
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 1412500000.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
THYROCARE.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
THYROCARE.NS income_statement (annual, 2025-03-31) — +Operating Expense: 3537600000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 937600000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — +Total Revenue: 6807100000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 1871600000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 762100000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 762100000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 730000000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 730000000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -2416200000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2416200000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 789900000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 789900000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -235700000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -235700000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Amortization: 10800000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 10800000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 10600000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 10600000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 159073599.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 156115108.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Basic EPS: 5.75
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 1.39
THYROCARE.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 93000000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 704900000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 704900000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -334800000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 246800000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 246800000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 529900000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 529900000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 176800000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 176800000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1917600000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1917600000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -953100000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 176800000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 176800000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 9900000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -267500000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 302800000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Change In Payable: 361000000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -307900000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 111300000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 83800000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Common Stock: 529900000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 529900000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -953100000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 5467600000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 5467600000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 400000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 141500000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 141500000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 1911600000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 494700000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Current Assets: 3377200000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 3377200000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 77600000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 77600000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Current Debt: 0.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 0.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 77600000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 77600000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 23800000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 23800000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 1218400000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1218400000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 10000000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 10000000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Depreciation: 541800000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 552600000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 552600000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 137700000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 541800000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 137700000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 159552738.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 157246377.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Diluted EPS: 5.74
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.38
THYROCARE.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 915100000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 217000000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 1700000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 1700000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — EBIT: 1484900000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — EBIT: 478900000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — EBITDA: 2037500000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — EBITDA: 616600000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — End Cash Position: 176800000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -1304200000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 19100000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 19100000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 1464300000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -88100000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -100000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 371200000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Goodwill: 1082100000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 1082100000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 1130500000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1130500000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 965700000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 965700000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 4399200000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 4399200000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Gross Profit: 4895500000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 1376900000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Interest Expense: 30500000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 7000000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 30500000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 7000000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Interest Income: 51000000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 51000000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -30700000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 19700000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Inventory: 465400000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 465400000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 5467600000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 5467600000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -411100000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 10600000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 10600000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Investmentsin Associatesat Cost: 241700000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 241700000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 400000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 0.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 317200000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 317200000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 169200000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 169200000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 0.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 0.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 169200000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 169200000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 0.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -215900000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 241700000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 241700000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 69400000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 69400000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 3235600000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 3235600000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 3000000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 3000000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Minority Interests: 7600000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 1300000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: -112500000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 400000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Net Income: 915100000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Net Income: 217000000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 915100000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 217000000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 907500000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 215700000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 915100000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 217000000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 915100000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 217000000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 1468800000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 907500000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 215700000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Net Interest Income: 13600000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -7000000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 16400000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -215900000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -215900000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: 13600000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -7000000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Net PPE: 1983000000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 1983000000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -334700000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 4337100000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 4337100000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 85300000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 85300000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 69400000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 69400000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 91900000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 91900000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 1949300000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 616600000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Normalized Income: 860065965.35
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 217000000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 1799100000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Operating Income: 1357900000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Operating Income: 439300000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Operating Revenue: 6807100000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 1871600000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 158979261.00